Europe's electrification strategy is ambitious but constrained by lagging grid infrastructure, creating bottlenecks that are ...

Q1 2026 Earnings Call April 28, 2026 4:30 PM EDTCompany ParticipantsPriya Vedaraman - Senior Vice President of FinanceAnthony Zook ...

The chart below gets to the heart of the matter – the AI tailwind that is powering Google more broadly and Google Cloud ...

WANI's push, India's public WiFi expansion faces weak business models and poor infrastructure, raising questions over its ...

Q1 2026 Earnings Call April 28, 2026 8:00 AM EDTCompany ParticipantsJan Strecker - Head of Investor RelationsStephan Leithner ...

In today's security landscape, some of the most dangerous vulnerabilities aren't flagged by automated scanners at all. These ...

According to MarketsandMarketstm, the global OCP Rack Market is projected to grow from USD 2.02 billion in 2026 to USD 4.32 ...

The SaaSpocalypse has created a compelling hunting ground. We think Readytech is worth 2-4x the current price, and a likely ...

In a conversation with Pharmaceutical Executive, Morten Graugaard, CEO, Orbis Medicines, discussed FDA’s approval of Icotyde as an early validation point for oral biologics, describing it as a ...

GAAP EPS -- $0.34 per share; Adjusted EPS -- $0.35 per share, an increase from $0.31 and $0.33 per share in Q4 2025, ...

Operator: Hello and thank you for standing by. My name is Bella, and I will be your conference operator today. At this time, ...